Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.

Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.

Item
http://www.wikidata.org/entity/Q43843771
Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap n collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2)NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinonesChemotherapy-induced toxicity is highly heritable in Drosophila melanogasterPharmacogenomics and stomach cancer.Quinone reductases multitasking in the metabolic world.Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites.Clinical implications of genetic polymorphisms on stomach cancer drug therapy.C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin.Quinone reductase 2 is a catechol quinone reductaseGenetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.Evaluating the role of admixture in cancer therapy via in vitro drug response and multivariate genome-wide associations.Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase and glutathione S-transferase M1 polymorphisms and childhood asthma.Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
P2860

Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.

Item
http://www.wikidata.org/entity/Q43843771
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Clinical significance of a NAD
@nl
Clinical significance of a NAD ...... chemotherapy with mitomycin C.
@en
type
label
Clinical significance of a NAD
@nl
Clinical significance of a NAD ...... chemotherapy with mitomycin C.
@en
prefLabel
Clinical significance of a NAD
@nl
Clinical significance of a NAD ...... chemotherapy with mitomycin C.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Clinical significance of a NAD ...... chemotherapy with mitomycin C.
@en
P2093
P304
P31
P356
10.1097/00008571-200201000-00005
P433
P478
P577
P698
P921